CBS News image for Patient dies by suicide after "insurance issue" delayed medicine for lung disease flare-ups - CBS News

📰 General · CBS News

Patient dies by suicide after "insurance issue" delayed medicine for lung disease flare-ups - CBS News

From CBS News via USVI News: Hours after experiencing a flare-up related to chronic obstructive pulmonary disease, Kenney Blewett of Kyle, Texas, died by suicide in June.

USVInews.com User Network Contributor

Kyle, Texas — Kenney Blewett was diagnosed with lung disease more than a decade ago but started experiencing flare-ups this year that made him feel like he couldn't breathe.

Blewett described those flare-ups as "the scariest thing in the world," said his wife, Cindy, adding that while the episodes typically lasted no more than a few minutes, they had become more frequent.

On top of that, simple tasks, like taking out the trash, left Blewett winded. He rarely left the house and had recently lost 45 pounds. "That sounds like cancer," Cindy remembered one of his doctors said. It was clear, she said, that her husband's poor health, tied to decades of smoking, was getting worse.

That's why, on June 2, Blewett's pulmonologist wrote him a prescription for a new medication to improve the terrifying breathing issues caused by chronic obstructive pulmonary disease, or COPD. But the prescription wasn't immediately filled. Two days after that doctor appointment, Blewett received an email from Walgreens explaining that, "due to an insurance issue that we're working to resolve," the medication was delayed.

"He was hopeful that it would work," Cindy said of the drug, two months after her husband's death. "I wish we had the chance to find out."

Insurance delays and denials have become an infamous feature of the American healthcare system, with nearly 7 in 10 adults calling them "a major problem," in a January KFF Health Tracking Poll.

In June 2025, six months after UnitedHealthcare's CEO was shot in New York, the Trump administration announced a highly publicized industry pledge, signed by dozens of major health insurers, to remove some of the barriers that block or delay patients from accessing doctor-recommended care. And yet that pledge was voluntary, and it carries no penalties if companies fail to comply. Indeed, a report published by KFF Health News in July found that some insurers that signed the pledge would not implement all the promised initiatives as originally outlined.

In recent years, lawmakers in most states, including Texas, have attempted to address delays and denials by regulating the insurance industry in the absence of substantial federal reform. But most health insurance plans, including traditional Medicare policies and employer-sponsored offerings, which together cover more than half of all Americans, typically aren't under state jurisdiction.

Even some medical office staff and pharmacy employees find the patchwork of state and federal insurance rules and regulations confusing, a problem that is poised to become more complicated as artificial intelligence plays a larger role in approving and processing claims.

"It's just gotten completely out of hand," said Matt Toresco, CEO of Archō, a patient advocacy and consulting company. He argued that patients need more assistance facing insurance hurdles.

The Blewetts' story illustrates how navigating these complexities remains a herculean task for patients and their caregivers.

Cindy has sought answers from Medicare, Kenney's private Part D drug plan, his pulmonologist's office, and Walgreens. She still has questions about who was responsible for the medication delay and how the holdup could have been prevented.

If the COPD flare-up Blewett experienced on the afternoon of Sunday, June 7, could have been avoided, she wondered, would he still have chosen to die by suicide that night?

"Complex and convoluted"

During that first week of June, Cindy said her husband repeatedly asked if his prescription — a liquid medication meant to be inhaled through the nebulizer machine Kenney owned — was ready to be picked up from Walgreens.

Cindy said she wasn't initially surprised or worried by the delay. Since its acquisition by a private equity firm last year, Walgreens has cut thousands of jobs across the country, according to the Private Equity Stakeholder Project. Cindy said in August that their Walgreens pharmacy in Kyle seemed to her to have been understaffed for months, and that prescriptions were being filled more slowly.

When Cindy called the pharmacy a few days after Kenney's appointment to find out more about the insurance delay, she said, a Walgreens employee told her the prescription required prior authorization. Also called preapproval or precertification, prior authorization is a practice widely used by health insurers that requires medical providers to seek permission before their patients may receive covered treatment.

This article is republished through the USVI News affiliate desk. Reporting, analysis, and viewpoints are those of the original publisher and do not necessarily reflect USVI News.

Read more at CBS News